the STIM-trial
Completed
- Conditions
- breast cancer, controlled ovarian stimulation, estradiol, tamoxifen, letrozole.borstkanker, ovariele stimulatie, oestradiol, tamoxifen, letrozol.
- Registration Number
- NL-OMON21429
- Lead Sponsor
- Academical Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 159
Inclusion Criteria
Age 18 – 43 years
-Confirmed breast cancer (ER+, ER- or unknown ER status)
Exclusion Criteria
- Contraindication to study medication
- Use of medication that opposes effect of study medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is number of oocytes retrieved at follicle apsiration.
- Secondary Outcome Measures
Name Time Method - Number of mature oocytes retrieved<br /><br>- Number of oocytes or embryos banked<br /><br>- Peak E2 levels during COS defined as serum E2 level measured on the day of ovulation trigger